FDA reviewers unconvinced on Teva Parkinson’s drug (Reuters)
Reuters – Teva Pharmaceutical Industries Ltd’s clinical trials of its Parkinson’s drug Azilect left U.S. drug reviewers unconvinced that the treatment slows the disease’s progression.
Good Health is Your Greatest Wealth……Virgil
Reuters – Teva Pharmaceutical Industries Ltd’s clinical trials of its Parkinson’s drug Azilect left U.S. drug reviewers unconvinced that the treatment slows the disease’s progression.